Cargando…
Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation
Nonstructural protein 1 (Nsp1) of SARS‐CoV‐2 inhibits host cell translation through an interaction between its C‐terminal domain and the 40S ribosome. The N‐terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID‐19 disease progression. Here,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081967/ https://www.ncbi.nlm.nih.gov/pubmed/35434785 http://dx.doi.org/10.1002/1873-3468.14354 |
_version_ | 1784703108364894208 |
---|---|
author | Kumar, Pravin Schexnaydre, Erin Rafie, Karim Kurata, Tatsuaki Terenin, Ilya Hauryliuk, Vasili Carlson, Lars‐Anders |
author_facet | Kumar, Pravin Schexnaydre, Erin Rafie, Karim Kurata, Tatsuaki Terenin, Ilya Hauryliuk, Vasili Carlson, Lars‐Anders |
author_sort | Kumar, Pravin |
collection | PubMed |
description | Nonstructural protein 1 (Nsp1) of SARS‐CoV‐2 inhibits host cell translation through an interaction between its C‐terminal domain and the 40S ribosome. The N‐terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID‐19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79–89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS‐CoV‐2 5′ untranslated region enhances translation of mRNA, it does not protect from Nsp1‐mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition. |
format | Online Article Text |
id | pubmed-9081967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90819672022-05-09 Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation Kumar, Pravin Schexnaydre, Erin Rafie, Karim Kurata, Tatsuaki Terenin, Ilya Hauryliuk, Vasili Carlson, Lars‐Anders FEBS Lett Research Letters Nonstructural protein 1 (Nsp1) of SARS‐CoV‐2 inhibits host cell translation through an interaction between its C‐terminal domain and the 40S ribosome. The N‐terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID‐19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79–89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS‐CoV‐2 5′ untranslated region enhances translation of mRNA, it does not protect from Nsp1‐mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition. John Wiley and Sons Inc. 2022-04-25 2022-05 /pmc/articles/PMC9081967/ /pubmed/35434785 http://dx.doi.org/10.1002/1873-3468.14354 Text en © 2022 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Letters Kumar, Pravin Schexnaydre, Erin Rafie, Karim Kurata, Tatsuaki Terenin, Ilya Hauryliuk, Vasili Carlson, Lars‐Anders Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title | Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title_full | Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title_fullStr | Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title_full_unstemmed | Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title_short | Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation |
title_sort | clinically observed deletions in sars‐cov‐2 nsp1 affect its stability and ability to inhibit translation |
topic | Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081967/ https://www.ncbi.nlm.nih.gov/pubmed/35434785 http://dx.doi.org/10.1002/1873-3468.14354 |
work_keys_str_mv | AT kumarpravin clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT schexnaydreerin clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT rafiekarim clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT kuratatatsuaki clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT tereninilya clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT hauryliukvasili clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation AT carlsonlarsanders clinicallyobserveddeletionsinsarscov2nsp1affectitsstabilityandabilitytoinhibittranslation |